Munzenrider, John E.
Massachusetts General Hospital,
United States
2025 Rank: 114058
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 4330 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114058 | 126808 |
| Total Cites | 11531 | 12277 |
| H-index | 48 | 51 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 95 | 96 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 639 | 657 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2733 | 2927 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8665 | 8994 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
6.08%
|
|
Munzenrider, John E.
Massachusetts General Hospital,
United States
2024 Rank: 109194
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 4220 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109194 | 122484 |
| Total Cites | 11095 | 11807 |
| H-index | 47 | 49 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 90 | 91 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 621 | 639 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2640 | 2826 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8317 | 8635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
6.03%
|
|
Munzenrider, John E.
Massachusetts General Hospital,
United States
2023 Rank: 102432
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 4019 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102432 | 114550 |
| Total Cites | 10694 | 11401 |
| H-index | 47 | 49 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 89 | 90 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 603 | 621 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2580 | 2765 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7964 | 8280 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
6.20%
|
|
Munzenrider, John E.
Massachusetts General Hospital,
United States
2022 Rank: 97624
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 3855 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97624 | 110158 |
| Total Cites | 9955 | 10621 |
| H-index | 46 | 48 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 84 | 85 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 563 | 580 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2403 | 2585 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7420 | 7720 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
6.27%
|
|
Munzenrider, John E.
Massachusetts General Hospital,
United States
2021 Rank: 94169
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 3754 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94169 | 107243 |
| Total Cites | 9586 | 10228 |
| H-index | 46 | 47 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 82 | 83 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 542 | 559 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2312 | 2487 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7140 | 7425 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.38 |
| Self-Citation Percentage |
6.28%
|
|
Munzenrider, John E.
Massachusetts General Hospital,
United States
2020 Rank: 86548
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Ophthalmology & Optometry
Rank in SubField 1: 3634 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86548 | 98302 |
| Total Cites | 9117 | 9748 |
| H-index | 45 | 47 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 80 | 81 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 524 | 541 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 2225 | 2405 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6749 | 7021 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.39 |
| Self-Citation Percentage |
6.47%
|
|